osteoporosis; bone turnover markers; vertebral fracture; bone mineral density
Abstract :
[en] Objective: To analyse the interest of baseline levels and short-term (3-months) changes in serum osteocalcin (BGP), serum bone-specific alkaline phosphatase (BALP) and urinary C-telopeptide of type I collagen/creatinine ratio (U-TX) to predict 3-years changes in bone mineral density (BMD) and spinal deformity index (SDI) in postmenopausal osteoporotic women. Methods: Data were derived from a cohort of 603 osteoporotic women corresponding to the placebo arm of a 3-years prospective, double-blind study. Results: Baseline values of BALP, BGP and U-CTX were negatively and significantly correlated with baseline spinal BMD. Significant correlations were also observed between the changes in BMD observed after 36 months at the spine and baseline BALP (r = 0.20, P = 0.0001), BGP (r = 0.09, P = 0.05) and U-CTX (r = -0.11, P = 0.02). At 3 years, 71 women (15.9%) showed an increase in their SDI, corresponding to the occurrence of at least one new vertebral deformity. Baseline values of the four bone turnover markers (BTM) were not significantly related to the occurrence of new vertebral deformities. However, when considering the changes in the BTM observed after 3-months of follow-up, BGP (P = 0.003) and U-CTX (P = 0.047) were identified as significant predictors of an increase of SDI. The associated odds ratios (95% confidence interval (CI)) were 10.922 (2.218-53.78) for unit changes of log BGP and 1.369 (1.003-1.867) for unit changes of log U-CTX. The relative risk (RR) (IC 95%) of having a new vertebral fracture over 36 months was 0.31 (0.15-0.65) when being in the lowest quartile of 3-months changes in BGP as compared with the highest. Conclusion: We conclude that two sequential measurements of BGP and U-CTX performed at 3-months intervals could be of interest to identify postmenopausal osteoporotic women with the highest risk to present new vertebral deformities. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics) Geriatrics Sociology & social sciences
Author, co-author :
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique
Collette, Julien ; Centre Hospitalier Universitaire de Liège - CHU > Chimie médicale
Delmas, Pierre
Rouillon, Alain
Roux, Christian
Seidel, Laurence ; Université de Liège - ULiège > Département des sciences de la santé publique > Informatique médicale et biostatistique
Richy, Florent
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique
Language :
English
Title :
Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women
Melton L.J. III, Khosla S., Atkinson E.J., O'Fallon W.M., Riggs B.L. Relationship of bone turnover to bone density and fractures. J. Bone Miner. Res. 12:1997;1083-1091.
Marshall D., Johnell O., Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br. Med. J. 312:1996;1254-1259.
Delmas PD. The role of markers of bone turnover in the assessment of fracture risk in postmenopausal women, Osteoporesis Int. 1998;8(Suppl. 1):S32-6.
Garnero P., Sornay-Rendu E., Chapuy M.-C., Delmas P.D. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J. Bone Miner. Res. 11:1996;337-349.
Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and risk of fracture in postmenopausal women: the OFELY study, J Bone Miner Res 2000;15:1526-36.
Garnero P., Hausherr E., Chapuy M.-C., Marcelli C., Grandjean H., Muller C., et al. Markers of bone resoprtion predict hip fracture in elderly women: the EPIDOS prospective study. J. Bone Miner. Res. 11:1996;1531-1538.
Keen R.W., Nguyen T., Sobnack R., Perry L.A., Thompson P.W., Spector T.D. Can biochemical markers predict bone loss at the hip and spine: a 4-years prospective study of 141 early postmenopausal women. Osteoporesis Int. 6:1996;399-406.
Reginster J.Y., Christiansen C., Roux C., Fechtenbaum J., Rouillon A., Tou K.P. Intermittent cyclic tiludronate in the treatment of osteoporosis. Osteoporosis Int. 12:2001;169-177.
Genant H.K., Wu C.Y., Van Kuijk C., Nevitt M.C. Vertebral fracture assessment using a semi-quantitative technique. J. Bone Miner. Res. 8:1993;984-996.
Tromp A.M., Ooms M.E., Popp-Snijders C., Roos J.C., Lips P. Predictors of fractures in elderly women. Osteoporosis Int. 11:2000;134-140.
Riis B.J., Hansen M.A., Jensen A.M., Overgaard K., Christiansen C. Low bone mass and fast rate of bone loss at menopause: equal risk factors for future fracture: a 15-years follow-up study. Bone. 19:1996;9-12.
Cummings S.R., Black D.M., Nevitt M.C., Browner W., Cauley J., Ensrud K., et al. Bone density at various sites for prediction of hip fractures. Lancet. 341:1993;72-75.
Dresner-Pollak R., Parker R.A., Poku M., Thompson J., Seibel M.J., Greespan S.L. Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif. Tissue Int. 59:1996;328-333.
Steiger P., Cummings S.R., Black D.M., Spencer N.E., Genant H.K. Age-related decrements in bone mineral density in women over 65. J. Bone Miner. Res. 7:1992;625-632.
Dawson-Hughes B., Dallal G.E. Effect of radiographic abnormalities on rate of bone loss from the spine. Calcif. Tissue Int. 46:1990;280-281.
Marcus R., Holloway L., Wells B., Greendale G., James M.K., Wasilauskas C., et al. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. J. Bone Miner. Res. 14:1999;1583-1595.
Melton L.J. III, Atkinson E.J., O'Connor M.K., O'Fallon W.M., Riggs B.L. Determinants of bone loss from the femoral neck in women of different ages. J. Bone Miner. Res. 15:2000;24-31.
Rosen C.J., Chesnut C.H. III, Mallinak N.J.S. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J. Clin. Endocrinol. Metab. 82:1997;1904-1910.
Bauer D.C., Sklarin P.M., Stone K.L., Black D.M., Nevitt M.C., Ensrud K.E., et al. Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures. J. Bone Miner. Res. 14:1999;1404-1410.
Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J, for the Committee of Scientific Advisor of the International Osteoporosis Foundation. The use of biochemical markers of bone turnover in osteoporosis, Osteoporosis Int. 2000;11(Suppl. 6): 2-17.
Jergas M., Genant H.K. Contributions of bone mass measurements by densitometry in the definition and diagnosis of osteoporosis. Meunier P.J. Osteoporosis: diagnosis and management. 1998;Martin Dunitz.
Cummings S.R., Nevitt M.C., Browner W.S., Stone D., Fox K.M., Ensrud K.E., et al. Risk factors for hip fracture in white women. New Engl. J. Med. 332:1995;767-773.
Ross P.D., Kress B.C., Parson R.E., Wasnich R.D., Armour K.A., Mizrahi I.A. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporosis Int. 11:2000;76-82.